drug

Results 1 - 25 of 42Sort Results By: Published Date | Title | Company Name
Published By: ETQ     Published Date: Jul 10, 2019
The FDA has announced plans to transition to standard ISO 13485:2016 for medical devices in 2019. In addition, the Medical Device Single Audit Program, MDSAP, has gained traction with full implementation set for 2019. Download this paper to learn more about these two changes from the U.S. Food and Drug Administration’s proposal to harmonize and modernize its Quality System Regulation (QSR).
Tags : 
    
ETQ
Published By: QuantumMethod     Published Date: Jul 28, 2011
There's growing recognition that marketers can no longer afford to wait for specific guidelines from the FDA. Jump on the social media bandwagon or be left blow'n in the wind. Are you prepared? b
Tags : 
digital, pharma, social media, advertising, fda, brand, consumer, drug
    
QuantumMethod
Published By: Automation Anywhere APAC     Published Date: Apr 18, 2019
Forbes recently referred to robotic process automation (RPA) as “a gateway drug to AI,” referencing its low barrier to entry compared to other technology choices within the AI realm. But while experts continue to tout the future of RPA, what can we expect of it in the short-term? Jump into this resource to get a peek at how experts are predicting RPA’s 2019 will pan out, including notable market shifts, major technology disruptions, and entirely new RPA use cases.
Tags : 
    
Automation Anywhere APAC
Published By: Automation Anywhere     Published Date: Feb 21, 2019
A recent Forbes article called robotic process automation (RPA) “a gateway drug to artificial intelligence (AI)”. In other words, RPA, provides organizations with a low barrier to entry into the AI world along with many of its benefits. Call it dipping a toe in the AI waters. What’s clear is RPA is on a tipping point. But will this growth continue? In this e-book we explore 7 predictions for the RPA market in 2019 from the market-leading platform, Automation Anywhere.
Tags : 
    
Automation Anywhere
Published By: Collaborative Consulting     Published Date: Dec 20, 2013
An integrated launch plan was just the start for helping to transform a research organization into a commercial entity. A successful commercial launch of an FDA-approved specialty drug included project management support to a cross-functional client team and development of a dashboard tool to track each function’s progress.
Tags : 
collaborative consulting, biotech organization, case study, launch strategy, biotech company, infrastructure, tailored segment, particular market
    
Collaborative Consulting
Published By: Collaborative Consulting     Published Date: Dec 20, 2013
Collaborative helped a research company transitioning to commercialization identify critical timelines, tasks, milestones and resources required to bring a new drug to market. As part of the project, leaders were given the information and tools they needed and the business began building the strong foundation necessary for a successful launch.
Tags : 
collaborative consulting, biotech organization, case study, launch strategy, biotech company, infrastructure, tailored segment, particular market
    
Collaborative Consulting
Published By: Senn Delaney     Published Date: Oct 22, 2009
To the casual observer, aircraft manufacturer Airbus UK and pharmaceutical giant GlaxoSmithKline (GSK) wouldn't appear to share a lot of common ground. Some would say that the worlds of building airplanes and producing the next blockbuster wonder-drug are light years apart. A closer look shows that these two organizations are more similar than one might initially think.
Tags : 
senn delaney, gsk, customer focused, brand management, customer-centric, employee management, employee engagement
    
Senn Delaney
Published By: UL EduNeering     Published Date: Jul 05, 2012
Good Manufacturing Practices (GMP) violations have become the new healthcare fraud as the Department of Justice (DOJ) tests out new legal theories under the False Claims Act (FCA). The Food and Drug Administration (FDA) has dusted off its regulatory authority to prosecute GMP violations.
Tags : 
fda, gmp, gcp, gxp, cms, osha, qsr, 21 cfr part 11
    
UL EduNeering
Published By: IBM Watson Health     Published Date: Dec 20, 2018
In this webinar, experts discuss how data and analytics can be applied to improve health program outcomes and how social determinants of health affect risk. It includes a case study on how the application of advanced analytic methods helped to decipher the impact of high-priced specialty drugs on the overall population. The experts also address how artificial intelligence can drive better decision-making, improve population health and cut costs.
Tags : 
government, health and human services, artificial intelligence, data, cognitive insights, long-term care, case study, analytics
    
IBM Watson Health
Published By: Automation Anywhere APAC     Published Date: Aug 15, 2019
Forbes recently referred to robotic process automation (RPA) as “a gateway drug to AI,” referencing its low barrier to entry compared to other technology choices within the AI realm. But while experts continue to tout the future of RPA, what can we expect of it in the short-term? Jump into this resource to get a peek at how experts are predicting RPA’s 2019 will pan out, including notable market shifts, major technology disruptions, and entirely new RPA use cases.
Tags : 
rpa, digital workforce, productivity, ocr
    
Automation Anywhere APAC
Published By: KPMG     Published Date: Oct 22, 2018
Top 5 Factors Every Bio-Tech and Pharmaceutical Company Must Keep in Mind. Successfully launching a product in the U.S. requires a balance across commercial strategy, government programs, and contracting operations. While the market holds significant opportunity, there are also complexities that need to be considered prior to launch. To prepare for the launch of your drug in the U.S. market, download a copy of Navigating the U.S. Government Market to help your organization remain compliant with government operational and pricing requirements.
Tags : 
    
KPMG
Published By: DrFirst     Published Date: Mar 13, 2015
For hospitals, medication reconciliation is critical to quality patient care. Obtaining a complete and accurate list of the patient’s medications sets the cornerstone for good patient care during the hospital stay, informing doctors about treatments in progress, and arming them to prevent potentially harmful drug interactions.
Tags : 
drfirst, hospital, solutions, medhx, emr, electronic, medical records, reconciliation
    
DrFirst
Published By: Excellus BlueCross BlueShield     Published Date: Jul 25, 2019
Each year it seems pharmacy costs are taking a larger bite out of businesses like yours. We’re here to relieve some of the burden and help you reach your business goals by putting the sound advice you need right at your fingertips.
Tags : 
pharmacy costs, health care costs, chronic health conditions, prescription costs, pharmacy benefits, medical and pharmacy integration, pharmacy benefits managers, pharmacy claims
    
Excellus BlueCross BlueShield
Published By: Avetta     Published Date: Sep 17, 2019
In the beginning of 2019, a National Safety Council (NSC) study revealed that for the first time in US recorded history, the odds of dying from an opioid overdose (1:96) surpassed those of dying in an auto accident (1:103). As a result, opioid overdoses are now the number one cause of preventable injury deaths in the United States. The growing trend of opioid-related workplace incidents is a major concern for supply chains across the world. In fact, a recent study by Massachusetts Department of Public Health shows higher opioid overdose incidents occurring in industries that have a higher chance of worker-related injury. Among these, construction and manufacturing are the two industries most heavily affected. This whitepaper discusses tips for dealing with the opioid epidemic and gives clarity around OSHA drug testing regulations.
Tags : 
    
Avetta
Published By: Actiance, Inc.     Published Date: Jan 15, 2015
Social Media Risks and Benefits for the Pharmaceuticals Industry Drug makers are just beginning to realize how social networks can improve business processes. Social media helps your organization share information and exchange ideas with your customers quickly, but doing so can involve considerable risk. That’s because social media is subject to the scrutiny of regulators, legislators, and litigators. So, what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA. On top of that, increasing litigation has made it a business requirement to consider solutions that help bring down skyrocketing legal costs. Not having technology in place to help manage these requirements and increasing risks, or doing so without careful planning, can be a costly mistake. Read this paper to gain an understanding of: What the regulatory landscape of the pharmaceuticals industry looks like What concerns you should be aware of f
Tags : 
social media, increased risks, business processes, regulatory requirements
    
Actiance, Inc.
Published By: MarkLogic     Published Date: Mar 29, 2018
It’s your golden opportunity: Rapidly integrate and harmonize data silos. Enhance drug discovery. Achieve faster time to insight. Get to market faster — all with less cost than you think. Explore how Life Sciences organizations can accelerate Real World Evidence (RWE) in a comprehensive and cost efficient manner. Download this white paper to learn about challenges, solutions and most importantly — how to equip your organization for success.
Tags : 
manufacturers, organizations, integration, optimization, data, quality
    
MarkLogic
Published By: MarkLogic     Published Date: May 07, 2018
Learn how Life Sciences organizations can accelerate Real World Evidence by achieving faster time to insight with a metadata-driven, semantically enriched operational platform. Real World Evidence (RWE) is today’s big data challenge in Life Sciences. Medical records, registries, consultation reports, insurance claims, pharmacy data, social media, and patient surveys all contain valuable insights that Life Sciences organizations need to ascertain and prove the safety, efficacy, and value of their drugs and medical devices. Learn how Life Sciences organizations can accelerate RWE with a metadata-driven, semantically enriched operational platform that enables them to: • Unify, harmonize and ensure governance of information from diverse data sources • Transform information into evidence that proves product efficacy and safety • Identify data patterns, connections, and relationships for faster time to insight
Tags : 
data, integration, drug, device, manufacture, science
    
MarkLogic
Published By: IBM Watson Health     Published Date: Dec 13, 2017
Clinical decision support solutions are critical to delivering quality care, but how do you know which tools are most effective? In this video, David Bordewyk, national director for clinical solutions at Truven Health, explains five considerations for evaluating current or prospective solutions. First, the tool should provide evidence-based, actionable recommendations. Learn how to determine whether that’s the case, as well as how to identify tools that provide comprehensive information, information that’s consistent, and information that’s easy to find and access. Additionally, the tool should provide access from multiple types of devices and the vendor should offer ongoing user training and support.
Tags : 
clinical solutions, clinical decision support solution, clinical decision tool, technical support, optimized care, evidence-based recommendations, clinical solution vendor, drug reference
    
IBM Watson Health
Published By: 3M     Published Date: Mar 19, 2019
The intent of this technical bulletin is to summarize and clarify the respiratory protection guidance from both USP and NIOSH for workers who handle hazardous drugs in the healthcare environment. Download now to learn more.
Tags : 
    
3M
Published By: Medidata     Published Date: Nov 10, 2017
Founded by physicians committed to advancing medical science, Worldwide Clinical Trials is out to change how the world experiences CROs. From early phase and bioanalytical sciences through late phase and post-approval, they provide full-service drug development services across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID) and rare diseases.
Tags : 
    
Medidata
Published By: Netezza IBM US     Published Date: May 09, 2012
With the amount of complex biological data increasing exponentially, the need intensifies for more insightful analysis on developmental drugs, their effects on humans and inter-drug relationships.
Tags : 
pharmaceutical, drug, ibm, analytics
    
Netezza IBM US
Published By: Siemens     Published Date: Jun 06, 2014
In implementing its patient portal, Main Line Health’s goal was to create a one-stop portal for the entire health system. With four acute-care hospitals, several outpatient facilities, a physical medicine and rehab hospital and a drug and alcohol treatment center, Main Line Health needed a solution that could quickly relay information from multiple points of care to thousands of patients.
Tags : 
siemens, hie, clinical workflows, care coordination, reduce costs, streamline communication, healthcare, patient portal
    
Siemens
Published By: Zebra Technologies     Published Date: Sep 07, 2017
In the age of evolving shopper expectations and technology advancements, the global retail industry is in the midst of a profound shift in retail operations. To gain a deeper understanding of retailers’ focus, concerns and investment plans, Zebra conducted a global research study across a wide spectrum of retail segments, including: specialty stores, department stores, apparel merchants, supermarkets, electronics, home improvement and drugstore chains. The results of this study are shared in this 2017 Retail Vision Study.
Tags : 
inventory management, staff communication, guest safety, guest security, mobile ordering, payment solutions, loyalty/membership/rewards, access card printers
    
Zebra Technologies
Published By: Zebra Technologies     Published Date: May 02, 2018
Up to 5% of all hospitalized patients are affected by ADEs. Implementing a comprehensive Barcode Medication Administration (BCMA) program can help, reducing medication errors up to 80%. In this white paper Zebra Technologies uncovers best practices for adopting Barcode Medication Administration, including: The importance of building a multidisciplinary implementation team The role of efficient, well-defined workflows How accurate data management and reporting are essential to ongoing BCMA success
Tags : 
safety, technology, zebra, medical, administration
    
Zebra Technologies
Published By: G+     Published Date: May 17, 2011
Gerson Lehrman Group Inc.'s panel of experts discusses the commercial, clinical, and regulatory challenges unique to orphan drug development.
Tags : 
gerson lehrman group, orphan drug, regulatory challenges, drug development, commercialization, clinical
    
G+
Previous   1 2    Next    
Search      

Related Topics

Add Research

Get your company's research in the hands of targeted business professionals.